Key Findings

This is a quick summary of the main discovery for each research paper we have published, organized issue by issue. Each key finding is below the article title, with a link to the abstract. 


Search key findings View Previous Lists


October 2018

Estimating mental health impacts of alcohol's harms from other drinkers: using propensity scoring methods with national cross‐sectional data from the United States

Financial troubles due to someone else's drinking and assaults perpetrated by drinking intimates (spouses, other partners or family members) are associated with worse mental health.

Link to Abstract

National Cancer Societies and their public statements on alcohol consumption and cancer risk

In 2017, the American Cancer Society and Canadian Cancer Society websites failed to state that alcohol is a group 1 carcinogen and can cause cancer at low doses, and that there is no safe threshold for cancer risk.

Link to Abstract

Drawing attention to a neglected injecting‐related harm: a systematic review of AA amyloidosis among people who inject drugs

Injecting‐related skin and soft tissue infections (SSTIs) are a significant cause of morbidity and premature mortality among people who inject drugs. There is strong evidence of an association between SSTIs and AA amyloidosis.

Link to Abstract

Adverse adult consequences of different alcohol use patterns in adolescence: an integrative analysis of data to age 30 years from four Australasian cohorts

Frequency of adolescent drinking is a major predictor of substance use problems in adulthood.

Link to Abstract

Effectiveness, safety and feasibility of extended‐release naltrexone for opioid dependence: a 9‐month follow‐up to a 3‐month randomized trial

Opioid‐dependent people who switch from buprenorphine–naltrexone treatment after 3 months to extended‐release naltrexone (XR-N) treatment for 9 months appear to have similar treatment completion rates, abstinence rates and adverse event profiles to people on XR‐N from the start of treatment.

Link to Abstract

Prevalence of youth gambling and potential influence of substance use and other risk factors throughout 33 European countries: first results from the 2015 ESPAD study

Underage gambling in Europe appears to be associated positively with alcohol, tobacco and other substance use (but not cannabis); truancy; going out at night; and active participation in sports.

Link to Abstract

Evolution of clinical characteristics and outcomes of synthetic cannabinoid receptor agonist exposure in the United States: analysis of National Poison Data System data from 2010 to 2015

In the US, hospitalization for toxicity from synthetic cannabinoid receptor agonists (Spice, Mamba) increased significantly between 2010 and 2015.

Link to Abstract

Cigarette brand diversity and price changes during the implementation of plain packaging in the United Kingdom

The implementation of plain packaging laws in the UK was associated with increased prices of manufactured cigarettes.

Link to Abstract

‘Real‐world’ compensatory behaviour with low nicotine concentration e‐liquid: subjective effects and nicotine, acrolein and formaldehyde exposure

People who use e-cigarettes with lower nicotine concentration e‐liquids may exhibit compensatory behaviour (e.g. higher number and duration of puffs) and higher negative affect, urge to vape and formaldehyde exposure.

Link to Abstract

Global statistics on alcohol, tobacco and illicit drug use: 2017 status report

In 2015, alcohol and tobacco use between them cost the human population more than a quarter of a billion disability‐adjusted life years, with illicit drugs costing further tens of millions.

Link to Abstract

Fetal assessment in buprenorphine‐maintained women using fetal magnetoencephalography: a pilot study

A novel biomagnetic technique may allow simultaneous quantification of cardiac and brain activities in buprenorphine‐exposed and non‐exposed fetuses in the third trimester.

Link to Abstract

Denise Kandel's classic work on the gateway sequence of drug acquisition

During the early 1970s Denise Kandel and her colleagues documented an ‘invariant sequence’ in initiation of drug use: starting with alcohol and tobacco, progressing to cannabis and then to other illicit, or ‘harder’ drugs. This observation became known as the ‘gateway sequence’ of drug use.

Link to Abstract